| Overview |
| bs-70098R |
| GABAA Receptor α3 Antibody |
| WB, IHC |
| Specific for endogenous levels of the ~51 kDa α3-subunit of the GABAA receptor. Immunolabeling is absent in α3-subunit knockout animals. |
| Mouse, Rat |
| Human, Dog, Bovine, Zebrafish, Non-Human Primate |
| Specifications |
| Unconjugated |
| Rabbit |
| Synthetic peptide from the N-terminal region of the α3 subunit of rat GABAA receptor. |
| Polyclonal |
| IgG |
| Lot Dependent |
| Antigen Affinity purification |
| 10 mM HEPES (pH 7.5), 150 mM NaCl, 100 µg per ml BSA and 50% glycerol. |
| Storage at -20°C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20°C. |
| Target |
| 24947 |
| P20236 |
| GABA A Receptor alphα3 antibody, GABA(A) receptor subunit alphα3 antibody, GABA(A) receptor subunit alpha-3 antibody, GABR A3 antibody, GABRα3 antibody, Gabra3 antibody, Gamma aminobutyric acid (GABA) A receptor alphα3 antibody, Gamma aminobutyric acid A receptor alphα3 antibody, Gamma aminobutyric acid receptor subunit alphα3 antibody, Gamma-aminobutyric acid receptor subunit alpha-3 antibody, GBRA3_HUMAN antibody, MGC33793 antibody |
| Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl- channel associated with the GABA-A receptor (GABA-A-R) subtype. GABA-A-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and substance abuse. The GABA-A-R is a multimeric subunit complex. To date six αs, four βs and four γs, plus alternative splicing variants of some of these subunits, have been identified (Olsen and Tobin, 1990; Whiting et al., 1999; Ogris et al., 2004). Injection in oocytes or mammalian cell lines of cRNA coding for α- and β-subunits results in the expression of functional GABA-A-Rs sensitive to GABA. However, coexpression of a γ-subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different α-subunits of the receptor (McKernan et al., 2000; Mehta and Ticku, 1998; Ogris et al., 2004; Pöltl et al., 2003). |
| Application Dilution |
| WB |
1:300-5000 |
| IHC |
|
Powered by Bioz